These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9376765)

  • 41. GABA receptor subtype antagonists in the nucleus accumbens shell and ventral tegmental area differentially alter feeding responses induced by deprivation, glucoprivation and lipoprivation in rats.
    Kandov Y; Israel Y; Kest A; Dostova I; Verasammy J; Bernal SY; Kasselman L; Bodnar RJ
    Brain Res; 2006 Apr; 1082(1):86-97. PubMed ID: 16516868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. gamma-Hydroxybutyrate (GHB) induces GABA(B) receptor independent intracellular Ca2+ transients in astrocytes, but has no effect on GHB or GABA(B) receptors of medium spiny neurons in the nucleus accumbens.
    Molnár T; Antal K; Nyitrai G; Emri Z
    Neuroscience; 2009 Aug; 162(2):268-81. PubMed ID: 19446011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of typical and atypical anxiolytics on the behavior and electrophysiological parameters of rats with model cerebrovascular pathology].
    Molodavkin GM; Cadikov MK; Voronina TA; Sadikova ZU; Meletova OK; Pchelkina MI; Larentsova LI; Gan'shina TS; Mirzoian RS
    Eksp Klin Farmakol; 2004; 67(6):16-9. PubMed ID: 15707007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats.
    Melis MR; Melis T; Cocco C; Succu S; Sanna F; Pillolla G; Boi A; Ferri GL; Argiolas A
    Eur J Neurosci; 2007 Aug; 26(4):1026-35. PubMed ID: 17672853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anxiolytic-like actions of the hexane extract from leaves of Annona cherimolia in two anxiety paradigms: possible involvement of the GABA/benzodiazepine receptor complex.
    López-Rubalcava C; Piña-Medina B; Estrada-Reyes R; Heinze G; Martínez-Vázquez M
    Life Sci; 2006 Jan; 78(7):730-7. PubMed ID: 16122763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Dependence of the strength of anxiolytic effect of tranquilizers on the level of anxiety in a conflict situation].
    Molodavkin GM; Voronina TA
    Biull Eksp Biol Med; 1996 Jan; 121(1):63-6. PubMed ID: 8680009
    [No Abstract]   [Full Text] [Related]  

  • 47. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
    Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
    Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The anxiolytic activity of calcium-channel blockers in tests of anxious behavior in mice and rats].
    Kozlovskiĭ VL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):84-95. PubMed ID: 10330709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acetylcholine in the accumbens is decreased by diazepam and increased by benzodiazepine withdrawal: a possible mechanism for dependency.
    Rada P; Hoebel BG
    Eur J Pharmacol; 2005 Jan; 508(1-3):131-8. PubMed ID: 15680263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A screening model for selecting atypical anxiolytics].
    Asrian AB; Dzhagatspanian IA
    Eksp Klin Farmakol; 1993; 56(4):58-60. PubMed ID: 8106059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
    Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
    Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
    Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
    J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Some doubts about the basic concept of hole-board test.
    Bilkei-Gorzó A; Gyertyán I
    Neurobiology (Bp); 1996; 4(4):405-15. PubMed ID: 9200132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The neurochemical characteristics of the rat septal nuclei in realizing the antiaversive effects of tranquilizers on different models of anxiety].
    Talalaenko AN; Pokramovich AI; Okhrimenko SV; Markova OP; Panfilov VIu; Vozdigan SA
    Ross Fiziol Zh Im I M Sechenova; 1997 Sep; 83(9):95-101. PubMed ID: 9487074
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative study of the action of tranquilizers on reinforcement systems].
    Marusov IV
    Farmakol Toksikol; 1979; 42(3):203-8. PubMed ID: 36295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Anxiety and the mechanisms of action of anxiolytics].
    Marino A; Costa R
    Recenti Prog Med; 1993 Feb; 84(2):129-41. PubMed ID: 8096650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The anxiolytic effect of small cumulative doses of oxypertin in rats during the anxiety test and their possible neurochemical correlates in the hypothalamus and striatum].
    Nitsch F; Hassler R; Kim JS; Bak IJ
    Nervenarzt; 1976 Jan; 47(1):40-5. PubMed ID: 2888
    [No Abstract]   [Full Text] [Related]  

  • 59. [The mediator mechanisms of the ventral hippocampus in anxiety states formed by different aversive exposures].
    Talalaenko AN; Krivobok GK; Stakhovskiĭ IuV; Chernikov AV; Shekhovtsov AA; Shevchenko SL
    Biull Eksp Biol Med; 1992 Oct; 114(10):374-6. PubMed ID: 1363197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The role of the neurochemical mechanisms of the basolateral amygdaloid nucleus in anxiety states of different aversive origins].
    Talalaenko AN; Perch NN; Babiĭ IuV; Panfilov VIu; Vozdigan SA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(1):184-7. PubMed ID: 8693787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.